QTRX - Latest News
Quanterix Corporation (QTRX), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $148.4M. Beta to the broader market is 1.01.
The article list below shows the most recent QTRX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent QTRX Headlines
Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals
gurufocus.com - Oct 7, 2026
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co. , Ltd.
Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals
businesswire.com - Oct 7, 2026
BILLERICA, Mass. & BEIJING--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biolo
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026
businesswire.com - Sep 25, 2026
BILLERICA, Mass. --(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX) today reported significant progress on the Content Innovation Engine it intro
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com - Sep 16, 2026
BILLERICA, Mass. --(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that on Sept
Quanterix Names Dr. Yuri Fesko Chief Medical Officer
gurufocus.com - Sep 14, 2026
Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr.
How News Affects QTRX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track QTRX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked QTRX news questions
- What is the latest QTRX news headline?
- The most recent QTRX headline (Oct 7, 2026) is "Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the QTRX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What QTRX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual QTRX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.